Exploiting the Role of O6-methylguanine-DNA-methyltransferase (MGMT) in Gastrointestinal Cancers

Overview

Journal Naunyn Schmiedebergs Arch Pharmacol

Specialty Pharmacology

Date 2024 Aug 21

PMID 39167167

Authors

Ziming Wu

Jie Dai

Jie Li

Zhengyu Zhang

Xbing Shen

Affiliations

Soon will be listed here.

Abstract

Gastrointestinal (GI) cancer is a prevalent disease and is recognized as the primary cause of cancer-related mortality globally. Therefore, there is an urgent need for novel diagnostic and treatment approaches for GC. The methylation of the O(6)-methylguanine DNA methyltransferase (MGMT) gene promoter is a significant factor in the development of colorectal cancer (CRC), namely in roughly 30-40% of cases where the cancer has spread. MGMT plays a role in the repair of DNA damage caused by methylating drugs like temozolomide (TMZ) and chloroethylating compounds like carmustine. As a result, it contributes to the resistance of chemotherapy when these agents are utilized. Although MGMT's role in the development of CRC is well established, its prognostic significance remains a subject of debate. Only a limited number of research have been conducted to examine the prognostic significance of MGMT methylation, yielding varying outcomes. This review explores the structural functions and repair processes of MGMT, focusing on the putative structural and functional significance of the N-terminal domain of MGMT. It also investigates the advancement of cancer treatment techniques that specifically target MGMT.

References

Abbotts R, Thompson N, Madhusudan S . DNA repair in cancer: emerging targets for personalized therapy. Cancer Manag Res. 2014; 6:77-92. PMC: 3933425. DOI: 10.2147/CMAR.S50497. View

Allan J, Travis L . Mechanisms of therapy-related carcinogenesis. Nat Rev Cancer. 2005; 5(12):943-55. DOI: 10.1038/nrc1749. View

Amatu A, Sartore-Bianchi A, Moutinho C, Belotti A, Bencardino K, Chirico G . Promoter CpG island hypermethylation of the DNA repair enzyme MGMT predicts clinical response to dacarbazine in a phase II study for metastatic colorectal cancer. Clin Cancer Res. 2013; 19(8):2265-72. DOI: 10.1158/1078-0432.CCR-12-3518. View

Bady P, Sciuscio D, Diserens A, Bloch J, van den Bent M, Marosi C . MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status. Acta Neuropathol. 2012; 124(4):547-60. PMC: 3444709. DOI: 10.1007/s00401-012-1016-2. View

Bae S, Lee H, Kim S, Kim W . Inactivation of O6-methylguanine-DNA methyltransferase by promoter CpG island hypermethylation in gastric cancers. Br J Cancer. 2002; 86(12):1888-92. PMC: 2375420. DOI: 10.1038/sj.bjc.6600372. View

Baumann S, Keller G, Puhringer F, Napieralski R, Feith M, Langer R . The prognostic impact of O6-Methylguanine-DNA Methyltransferase (MGMT) promotor hypermethylation in esophageal adenocarcinoma. Int J Cancer. 2006; 119(2):264-8. DOI: 10.1002/ijc.21848. View

Baylin S, Jones P . A decade of exploring the cancer epigenome - biological and translational implications. Nat Rev Cancer. 2011; 11(10):726-34. PMC: 3307543. DOI: 10.1038/nrc3130. View

Bouras E, Karakioulaki M, Bougioukas K, Aivaliotis M, Tzimagiorgis G, Chourdakis M . Gene promoter methylation and cancer: An umbrella review. Gene. 2019; 710:333-340. DOI: 10.1016/j.gene.2019.06.023. View

Cats A, Jansen E, van Grieken N, Sikorska K, Lind P, Nordsmark M . Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial. Lancet Oncol. 2018; 19(5):616-628. DOI: 10.1016/S1470-2045(18)30132-3. View

10.

Chen J, Huang Z, Duan Y, Xiao X, Jiang J, Zhang R . Aberrant DNA methylation of P16, MGMT, and hMLH1 genes in combination with MTHFR C677T genetic polymorphism and folate intake in esophageal squamous cell carcinoma. Asian Pac J Cancer Prev. 2012; 13(10):5303-6. DOI: 10.7314/apjcp.2012.13.10.5303. View

11.

Chen J, Li Z, Chen J, Du Y, Song W, Xuan Z . Downregulation of MGMT promotes proliferation of intrahepatic cholangiocarcinoma by regulating p21. Clin Transl Oncol. 2019; 22(3):392-400. DOI: 10.1007/s12094-019-02140-9. View

12.

Das M, Sharma S, Sekhon G, Jyoti Saikia B, Mahanta J, Phukan R . Promoter methylation of MGMT gene in serum of patients with esophageal squamous cell carcinoma in North East India. Asian Pac J Cancer Prev. 2014; 15(22):9955-60. DOI: 10.7314/apjcp.2014.15.22.9955. View

13.

Doecke J, Zhao Z, Pandeya N, Sadeghi S, Stark M, Green A . Polymorphisms in MGMT and DNA repair genes and the risk of esophageal adenocarcinoma. Int J Cancer. 2008; 123(1):174-80. DOI: 10.1002/ijc.23410. View

14.

Esteller M, Herman J . Generating mutations but providing chemosensitivity: the role of O6-methylguanine DNA methyltransferase in human cancer. Oncogene. 2004; 23(1):1-8. DOI: 10.1038/sj.onc.1207316. View

15.

Feng X, Xue F, He G, Ni Q, Huang S . Banxia xiexin decoction affects drug sensitivity in gastric cancer cells by regulating MGMT expression via IL‑6/JAK/STAT3‑mediated PD‑L1 activity. Int J Mol Med. 2021; 48(2). PMC: 8262654. DOI: 10.3892/ijmm.2021.4998. View

16.

Gerson S . MGMT: its role in cancer aetiology and cancer therapeutics. Nat Rev Cancer. 2004; 4(4):296-307. DOI: 10.1038/nrc1319. View

17.

Goder A, Nagel G, Kraus A, Dorsam B, Seiwert N, Kaina B . Lipoic acid inhibits the DNA repair protein O 6-methylguanine-DNA methyltransferase (MGMT) and triggers its depletion in colorectal cancer cells with concomitant autophagy induction. Carcinogenesis. 2015; 36(8):817-31. DOI: 10.1093/carcin/bgv070. View

18.

Hassel J, Sucker A, Edler L, Kurzen H, Moll I, Stresemann C . MGMT gene promoter methylation correlates with tolerance of temozolomide treatment in melanoma but not with clinical outcome. Br J Cancer. 2010; 103(6):820-6. PMC: 2966614. DOI: 10.1038/sj.bjc.6605796. View

19.

Javanmard S, Loktionova N, Fang Q, Pauly G, Pegg A, Moschel R . Inactivation of O(6)-alkylguanine-DNA alkyltransferase by folate esters of O(6)-benzyl-2'-deoxyguanosine and of O(6)-[4-(hydroxymethyl)benzyl]guanine. J Med Chem. 2007; 50(21):5193-201. PMC: 2597536. DOI: 10.1021/jm0705859. View

20.

Jin J, Xie L, Xie C, Zhou Y . Aberrant DNA methylation of MGMT and hMLH1 genes in prediction of gastric cancer. Genet Mol Res. 2014; 13(2):4140-5. DOI: 10.4238/2014.May.30.9. View